NO20004920D0 - Anvendelse av proteaseinhibitorer for behandling av hudskader - Google Patents

Anvendelse av proteaseinhibitorer for behandling av hudskader

Info

Publication number
NO20004920D0
NO20004920D0 NO20004920A NO20004920A NO20004920D0 NO 20004920 D0 NO20004920 D0 NO 20004920D0 NO 20004920 A NO20004920 A NO 20004920A NO 20004920 A NO20004920 A NO 20004920A NO 20004920 D0 NO20004920 D0 NO 20004920D0
Authority
NO
Norway
Prior art keywords
treatment
protease inhibitors
skin damage
skin
damage
Prior art date
Application number
NO20004920A
Other languages
English (en)
Other versions
NO20004920L (no
Inventor
Clive L Bunn
John Andrews
Phillip Sharp
Original Assignee
Biotech Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd filed Critical Biotech Australia Pty Ltd
Publication of NO20004920D0 publication Critical patent/NO20004920D0/no
Publication of NO20004920L publication Critical patent/NO20004920L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20004920A 1998-04-01 2000-09-29 Anvendelse av proteaseinhibitorer for behandling av hudsår NO20004920L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8031598P 1998-04-01 1998-04-01
US8468298P 1998-05-07 1998-05-07
PCT/IB1998/001917 WO1999049887A1 (en) 1998-04-01 1998-11-13 Use of protease inhibitors for treating skin wounds

Publications (2)

Publication Number Publication Date
NO20004920D0 true NO20004920D0 (no) 2000-09-29
NO20004920L NO20004920L (no) 2000-11-30

Family

ID=26763356

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004920A NO20004920L (no) 1998-04-01 2000-09-29 Anvendelse av proteaseinhibitorer for behandling av hudsår

Country Status (10)

Country Link
US (1) US6344189B1 (no)
EP (1) EP1071448A4 (no)
JP (1) JP2002526382A (no)
KR (1) KR20010042402A (no)
CN (1) CN1299286A (no)
AU (1) AU1170899A (no)
CA (1) CA2326438A1 (no)
IL (1) IL138594A0 (no)
NO (1) NO20004920L (no)
WO (1) WO1999049887A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP508798A0 (en) * 1998-08-05 1998-08-27 Biotech Australia Pty Limited Method of treating psoriasis
AUPQ380699A0 (en) * 1999-11-02 1999-11-25 Biotech Australia Pty Limited Protease inhibitors as modulators of periodontal wound healing
AU2003286258B2 (en) * 2002-11-20 2006-12-21 Arriva-Prometic Inc. Composition and method for treating inflammatory diseases using protease inhibitors
US7217690B2 (en) * 2003-10-07 2007-05-15 Kimberly-Clark Worldwide, Inc. Compositions of sunflower trypsin inhibitors
WO2009045543A1 (en) 2007-10-04 2009-04-09 The Regents Of The University Of California Treatment of conditions related to shock
PL2205623T3 (pl) * 2007-10-29 2016-09-30 Ochronne tetrapeptydy do pielęgnacji skóry
US8841258B2 (en) * 2009-09-28 2014-09-23 The Regents Of The University Of California Methods to accelerate tissue and wound healing rates and reduce swelling and scar formation
US9295715B2 (en) 2010-10-02 2016-03-29 The Regents Of The University Of California Minimizing intestinal dysfunction
JP6948741B1 (ja) * 2021-03-30 2021-10-13 株式会社セテカ 細胞賦活化剤、及びそれを含む皮膚外用組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202118A (en) 1987-12-18 1993-04-13 Immunex Corporation Method for promoting wound healing using IL-1
DE3829523A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von plasminogen-aktivator-inhibitor (pai-2) zur immunsuppression
EP0446315B1 (en) * 1989-09-05 1997-06-11 Biotechnology Australia Pty. Ltd. Process for the preparation of pai-2
DE69031271T2 (de) 1989-12-20 1998-02-26 Biotech Australia Pty Ltd Varianten von pai-2
EP0451130A3 (en) * 1990-04-05 1992-08-05 Baltimore Biotech, Inc. Use of amiloride and other pyrazine derivatives for preventing or treating ocular neovascularization
ATE146970T1 (de) * 1990-10-16 1997-01-15 John Lezdey Behandlung von entzündungen
DE4214215A1 (de) * 1992-04-30 1993-11-04 Behringwerke Ag Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen
DE4214999C2 (de) 1992-05-06 1994-07-14 Behringwerke Ag Reinigung von Plasminogen-Aktivator-Inhibitor 2 durch Immunaffinitätschromatographie
US5679350A (en) 1992-05-28 1997-10-21 The University Of Toledo Method of delivery of a medicament to a cancer cell using a pathway of plasminogen activator material
AU4847093A (en) * 1992-09-04 1994-03-29 Summit Technology, Inc. A plasmin activity reducing agent for treating a superficial corneal ablation wound and related screening method
JPH0782169A (ja) 1993-09-13 1995-03-28 Toray Ind Inc 創傷治療剤
US5599788A (en) 1994-07-01 1997-02-04 Advanced Tissue Sciences Method for accelerating skin wound healing with H3 protein
US5821220A (en) * 1995-06-07 1998-10-13 Andre Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US5693332C1 (en) 1995-08-11 2001-01-09 Univ California Human keratinocytes supported on a hydrophilic membrane and methods of using same to effect wound closure
US5919436A (en) * 1997-09-25 1999-07-06 The Board Of Regents Of The University Of Oklahoma Method of lightening skin

Also Published As

Publication number Publication date
AU1170899A (en) 1999-10-18
CN1299286A (zh) 2001-06-13
NO20004920L (no) 2000-11-30
EP1071448A1 (en) 2001-01-31
CA2326438A1 (en) 1999-10-07
IL138594A0 (en) 2001-10-31
EP1071448A4 (en) 2003-07-23
WO1999049887A1 (en) 1999-10-07
KR20010042402A (ko) 2001-05-25
US6344189B1 (en) 2002-02-05
JP2002526382A (ja) 2002-08-20

Similar Documents

Publication Publication Date Title
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
DE69924750D1 (de) Gerät zur thermischen behandlung von gewebe
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
NO20001870D0 (no) Ny fremgangsmõte for behandling
ATE344253T1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
NO20010053L (no) Farnesyl proteintransferaseinhibitorer for behandling av artropatier
ATE226573T1 (de) Heterozyklische metalloproteaseinhibitoren
NO20015274D0 (no) ACE-2 inhiberende forbindelser og fremgangsmåter for anvendelse derav
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
DE60136477D1 (de) Retinoide zur behandlung von emphysem
PT1206436E (pt) Retinoides para o tratamento de enfisema
NO991459L (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
FI964342A7 (fi) Halogeenimetyyliamideja IL-1beta-proteaasi-inhibiittoreina
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20010291D0 (no) Coadministrasjon av ACAT og MMP inhibitorer for behandling av aterosklerotiske sår
IT1306165B1 (it) Impiego di inibitori della sostanza p per il trattamento degliadenocarcinomi.
IT1296305B1 (it) Inibitori di metalloproteinasi loro uso terapeutico e procedimento per la produzione del composto di partenza nella loro
DE60042161D1 (de) Ppar delta-inhibitoren zur behandlung kardiovasculärer erkrankungen
IL138594A0 (en) Use of protease inhibitors for treating skin wounds
NO20010569D0 (no) Proteaseinhibitorer for anvendelse ved behandling av psoriasis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application